Generation of pathogenic TH17 cells in the absence of TGF-β signalling
National Institutes of Health · National Institute of Arthritis and Musculoskeletal and Skin Diseases · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,369
total citations
- FWCI
- 37.41
- Percentile
- 100%
- References
- 35
Citations per year
Authors
21- KGKamran GhoreschiCorresponding
National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases
- ALArian Laurence
National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases
- XYXiang‐Ping Yang
National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases
- CMCristina M. Tato
Merck & Co., Inc., Rahway, NJ, USA (United States)
- MJMandy J. McGeachy
Merck & Co., Inc., Rahway, NJ, USA (United States)
Topics & keywords
Topics
Keywords
- Transforming growth factor
- Interleukin 17
- Cell biology
- Cellular differentiation
- Biology
- Interleukin 3
- Interleukin 23
- Interleukin
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.